Three Dose Levels of a Maternal Respiratory Syncytial Virus Vaccine Candidate Are Well Tolerated and Immunogenic in a Randomized Trial in Nonpregnant Women

BACKGROUND: Respiratory syncytial virus (RSV) causes respiratory tract infections, which may require hospitalization especially in early infancy. Transplacental transfer of RSV antibodies could confer protection to infants in their first months of life. METHODS: In this first-in-human, placebo-contr...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwarz, Tino F, Johnson, Casey, Grigat, Christine, Apter, Dan, Csonka, Peter, Lindblad, Niklas, Nguyen, Thi Lien-Anh, Gao, Feng F, Qian, Hui, Tullio, Antonella N, Dieussaert, Ilse, Picciolato, Marta, Henry, Ouzama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Articles and Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200160/
https://www.ncbi.nlm.nih.gov/pubmed/34146100
http://dx.doi.org/10.1093/infdis/jiab317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200160/
https://www.ncbi.nlm.nih.gov/pubmed/34146100
http://dx.doi.org/10.1093/infdis/jiab317

Ejemplares similares